May 27, 2022
The University of Cincinnati's John Breneman, MD, spoke with Imaging Technology News about the completion of enrollment of the FAST-01 trial, the first FLASH proton therapy trial completed in humans.
June 28, 2022
MSN highlighted the University of Cincinnati's Jordan Kharofa and his recent research on how diet and the microbiome affect colorectal cancer risks in young populations.
August 10, 2022
Medium featured the research of the University of Cincinnati's Jiajie Diao, PhD, who recently published a paper showing early results that light-activated proteins can help normalize dysfunction within cells.
November 21, 2022
The University of Cincinnati Cancer Center's Davendra Sohal joined 55KRC's Simply Medicine program to discuss pancreatic cancer clinical trial options and screening during Pancreatic Cancer Awareness Month.
April 26, 2023
WFMZ-TV in Allentown, Pennsylvania highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.
April 6, 2023
U.S. News and World Report highlighted research led by the University of Cincinnati's Jordan Kharofa that found several enriched species, associated with enhanced tumor immune response, in the microbiomes of long-term pancreatic cancer survivors.
January 3, 2023
The University of Cincinnati's Caroline Billingsley, MD, was featured in a Q&A article on OncLive discussing the use of antibody-drug conjugates in ovarian cancer treatment.
September 12, 2022
The University of Cincinnati's Thomas Herzog, MD, was featured on 55KRC radio's Simply Medicine program to discuss a recent study that found that metastatic, or advance stage, cervical cancer cases are increasing in the United States.
September 16, 2022
WLWT and Yahoo News highlighted work being done by University of Cincinnati Cancer Center researchers to advance cancer care through new immunotherapy and cellular therapy treatments.
September 21, 2022
Medical News Today highlighted recent research led by the University of Cincinnati's Pier Paolo Scaglioni, MD, that found targeting components of lipid metabolism and synthesis could lead to an effective lung cancer treatment.